Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Patriot One Technologies (TSX.V: PAT) (OTCQB: PTOTF) and McMaster University Researchers Team Up to Commercialize Concealed Weapons Detection System

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is taking steps to commercialize its PATSCAN™ CMR technology, which features an innovative radar technology that can detect concealed weapons such as knives, guns, grenades, and suicide vests. The microwave radar system can identify moving targets – individuals who are carrying concealed weapons. Recently featured in a […]

Crexendo’s (CXDO) Revolutionary Cloud-Based Phone Systems Let Businesses ‘Cut the Cord’ Between Offices and the Outside World

Offering high-quality voice, data, and marketing solutions that help businesses focus on their core operations, Crexendo, Inc. (OTCQX: CXDO) is a competitive local exchange carrier (CLEC) cloud services company that offers award-winning cloud telecommunications, broadband Internet, and other cloud business services. The company provides critical voice and data technology infrastructure for startups, small and medium-sized […]

Algae Dynamics Corp. (ADYNF) is “One to Watch”

Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result […]

InMed Pharmaceuticals, Inc. (IMLFF) is a Player in the Billion Dollar Cannabis Biotech Market

Despite the fire-breathing from Attorney-General Jefferson Beauregard Sessions III, there is a distinct feeling that marijuana has entered the mainstream now that Goldman Sachs has initiated coverage on GW Pharma (NASDAQ: GWPH). GW Pharma is the biopharmaceutical that developed the cannabinoid-derived Sativex to treat spasticity due to multiple sclerosis (MS), now approved by regulatory authorities […]

Moxian, Inc. (NASDAQ: MOXC) Leveraging High Gross Margin and Existing SME Customer Base in China’s O2O Market

Moxian, Inc. (NASDAQ: MOXC) offers investors a high risk-high reward opportunity in China’s online-to-offline (O2O) marketplace, and the key is the high gross margin percentages of the company’s revenues, according to the SeeThruEquity (http://nnw.fm/dee5W) research report on the company. Shenzhen, China-based Moxian has a gross margin of 77.4% — second-highest of all of its significantly […]

InMed Pharmaceuticals, Inc. (IMLFF) Gains Attention for Its Operational Developments and Leadership Team

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team. Insider Financial highlighted InMed Pharmaceuticals as a “Cannabis […]

Nasdaq and Bats Square off on Market-Close Orders

The status quo never likes change, nor the upstarts that attempt to initiate innovation. When innovation and change occur, the entrenched typically lose prominence, certainly preeminence, and often times money. Disagreement and conflict ensue, but the strongest survive and seem to stay in power. It happens across the full spectrum of businesses, and it’s happening […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Advances Ricin Vaccine amid Toxin Threat

December 19, 2025

A recent “Times of India” report spotlighted the danger posed by ricin, a highly toxic plant-derived compound with no known antidote and a history of attempted misuse by extremist actors. Soligenix (NASDAQ: SNGX), a biopharmaceutical company focused on biodefense solutions, is developing a vaccine candidate known as RiVax(R) to protect against ricin exposure, positioning the company’s work at the […]

Rotate your device 90° to view site.